Fundraising Fox

Neil Exter

Investor

Partner at Third Rock Ventures · Board director at Cedilla Therapeutics, Inc. · Board director at Goldfinch BioPharma · Board director at Pliant Therapeutics

East Coast

Writes $100K – $5M checks · typically $1.5M

Find your path to Neil

350 people in our graph share verified history with Neil — schools, employers, funds. One of them is your warm intro.

John KimunlockedNeil: together at Harvard Business School (1992)
×5Neil: together at Harvard Business School
Neil: together at Stanford University
Neil: together at HP

About

Neil Exter is a retired partner at Third Rock Ventures, which he joined in 2007, where he concentrated on the formation, development and strategy of new companies. He brings more than 30 years of operating, business development and strategy experience spanning emerging and established biotechnology and technology companies. He trained as an electrical engineer, earning degrees from Cornell and Stanford before completing an MBA at Harvard Business School.

Contact· published on Neil's own website

Beyond investing

Education
Earned a B.S. in Electrical Engineering from Cornell University. Earned an M.S. in Electrical Engineering from Stanford University. Holds an MBA from Harvard Business School.

From Neil's own website — common ground for a warm intro.

Board director at Cedilla Therapeutics, Inc.

Intro paths

In turn, Neil can intro founders to Cedilla Therapeutics, Inc.'s investors below.

Board director at Goldfinch BioPharma

Intro paths

In turn, Neil can intro founders to Goldfinch BioPharma's investors below.

Board director at Pliant Therapeutics

Intro paths

In turn, Neil can intro founders to Pliant Therapeutics's investors below.

Co-founders at Pliant Therapeutics

BC
Bernard CoulieExecutive Officer, Director

Experience

  1. Third Rock VenturesRetired Partnercurrent2025 — present
  2. Third Rock VenturesPartner2007 — 2025
  3. Alantos PharmaceuticalsChief Business Officer2006 — 2007
  4. Millennium PharmaceuticalsVP Business Development2002 — 2006
  5. MacGregorEVP2000 — 2001
  6. Flexplay TechnologiesCEO1999 — 2000
  7. Wang LabsVP Business Development1992 — 1999
  8. Corporate DecisionsConsultant1991
  9. Stellar ComputerProject Leader1986 — 1990
  10. HPSales Development et al1979 — 1986

Deals · 7

Cedilla Therapeutics, Inc.Board seat

via Third Rock Ventures · filed Oct 2021 · $82.6M raise

Goldfinch BioPharmaBoard seat

via Third Rock Ventures · filed Jul 2020

Revolution MedicinesBoard seat

via Third Rock Ventures · filed Nov 2019 · $100.3M raise

Pliant TherapeuticsBoard seat

via Third Rock Ventures · filed Jul 2018 · $62.1M raise

Element ScienceBoard seat

via Third Rock Ventures · filed Aug 2016 · $25M raise

Rhythm PharmaceuticalsBoard seat

via Third Rock Ventures · filed Dec 2015 · $40M raise

CytomX TherapeuticsBoard seat

via Third Rock Ventures · filed Jan 2015 · $30M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

Decibel Therapeutics

Per SEC Form D filings.

Colleagues at Third Rock Ventures

Frequently asked questions

Who is Neil Exter?
Neil Exter is a retired partner at Third Rock Ventures, which he joined in 2007, where he concentrated on the formation, development and strategy of new companies. He brings more than 30 years of operating, business development and strategy experience spanning emerging and established biotechnology and technology companies. He trained as an electrical engineer, earning degrees from Cornell and Stanford before completing an MBA at Harvard Business School.
Where does Neil Exter work?
Neil Exter is Partner at Third Rock Ventures and Board director at Cedilla Therapeutics, Inc. and Board director at Goldfinch BioPharma and Board director at Pliant Therapeutics.
What check size does Neil Exter write?
Neil Exter typically writes checks of $100K – $5M.
What boards does Neil Exter sit on?
Neil Exter holds tracked board seats at Cedilla Therapeutics, Inc., CytomX Therapeutics, Decibel Therapeutics, Element Science, Goldfinch BioPharma, Pliant Therapeutics, Revolution Medicines, Rhythm Pharmaceuticals.
Where did Neil Exter go to school?
Neil Exter studied at Harvard Business School (MBA); Stanford University (MS, Electrical Engineering).

Same school

Shared employers